Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
about
Potential role for interleukin-10 in the immunosuppression associated with kala azarBalance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesisSodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human bloodInduction and abrogation of LACK reactive cells in the evolution of human leishmaniasisRegulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasisA recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library.High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load.Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral LeishmaniasisMacrophage and T-cell gene expression in a model of early infection with the protozoan Leishmania chagasi.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasisImmunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasisPlasmodium falciparum malaria and invasive bacterial co-infection in young African children: the dysfunctional spleen hypothesis.Up-regulation of Th1-type responses in mucosal leishmaniasis patientsImmunobiology of visceral leishmaniasis.Protein malnutrition impairs the immune response and influences the severity of infection in a hamster model of chronic visceral leishmaniasis.Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic stateCellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantumSplenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.Leishmaniases of the New World: current concepts and implications for future researchA factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responsesImmunoactivation and immunopathogeny during active visceral leishmaniasis.Whole blood assay and visceral leishmaniasis: Challenges and promises.Bone marrow parasite burden among patients with New World kala-azar is associated with disease severityLipopolysaccharide-Induced Cellular Activation May Participate in the Immunopathogenesis of Visceral Leishmaniasis Alone or in HIV Coinfection.Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.Functional and phenotypic changes in human lymphocytes after coincubation with Leishmania donovani in vitro.[Visceral leishmaniasis and B fulminant hepatitis association: case report].Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c miceLeishmaniasis in Sudan. Visceral leishmaniasis.Ultrastructural study on tissue alterations caused by trypanosomatids in experimental murine infections.Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis.Alteration of Fas and Fas ligand expression during human visceral leishmaniasis.Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental Leishmania chagasi infection.CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
P2860
Q24594397-360B73B6-5A6E-4213-A9CD-4181884A60E9Q25256772-0CD4534A-4FF6-4BB8-AA74-C77E43DB8239Q28344600-42F1E421-B003-483B-9B49-76466C8AB66AQ28367592-7DDAA1BE-85D8-4C3F-AF96-F8299B9DDE02Q28480551-3DDA04C9-7A8B-4DFC-B3F1-916814B221E9Q30452825-96C4A21A-5E07-4AB2-9930-37625582146AQ30654793-AB45F119-17C2-44CB-8557-6DE023E5C271Q30993317-33137F92-B43B-4AEF-A6F2-111B944347FCQ31060208-FC024287-54FC-41C5-8D2A-CD4DE18103FDQ33346267-4A7D7357-1ECA-46BC-A89B-268D31008319Q33719037-D2790810-A464-4D01-BDF3-61844D632B92Q33749424-A0E2264B-AAF0-4A78-A951-2DD5196FB270Q33963990-DD12785B-6784-48C7-A077-5444DB2468FCQ34008441-88C7B1CE-3784-4868-A1F3-E0FEED16CD9CQ34168838-D9E88FC7-A985-414E-8828-4D7AE4B0F0B8Q34259236-BBC767EE-5839-4C4B-A9BC-4BC4072D6C67Q34641680-8FB03D73-3F7D-4B28-9A84-02265805131DQ35107259-37A1F2B4-4A11-4E8C-ADC5-410EED66BCB3Q35601622-4CD07572-1E3D-44C4-9B55-A45346295B00Q35771655-22B67F36-8C60-4F6B-8D50-3FE3DE2B2B37Q36253846-636F954F-264D-49F1-A783-4C3B5D0DAC19Q36265092-F75FA1AF-D696-483E-8A3C-E49438596A25Q36640255-98FCF23F-603A-4699-983F-A89557094C71Q37194024-E0CDBBF5-F7D2-489B-95A9-808150FDBB64Q37628522-F1F880D0-5256-4140-950D-74B1DE0B425AQ37633356-A5ED506E-DA06-42F4-A665-4128DB7A64A4Q37680697-4821D450-CFEE-4189-B8A7-D88AA7BD4DBDQ39430377-0B6412C1-B87A-4A73-A2BB-41EE293986BDQ39529346-0C5EC6A5-199B-4A50-A78D-21135B4D7BFDQ39809664-2478F796-980F-4B8A-8000-AF3D8207B09CQ40428570-04E6AE38-B9E5-4E31-AA77-1873A74FE1D8Q40564194-CA0CA55C-509F-44A1-A434-F45DC924CE46Q40572422-782E8595-AE48-453B-949F-99C6EAAC154AQ40602460-269A279C-16FE-49EC-A59D-7E68728EEC7AQ41963043-4AB25812-B5D8-4BFA-B207-D5DF6E7FDBD5Q42653980-606B71C8-C7A7-480D-8569-5CAA8830B3B6Q43990705-5C7A84C1-87B6-4581-96B4-9DB9C0011C1BQ44805980-F71DE044-6666-4726-9936-769F68D083D3Q49562362-0456C7CB-15A9-4615-843E-C0F5AD965253Q57952511-58C1CF38-8A23-4783-8F1A-7D07E1585CA8
P2860
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@ast
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@en
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@nl
type
label
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@ast
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@en
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@nl
prefLabel
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@ast
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@en
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@nl
P2093
P2860
P356
P1476
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated
@en
P2093
E M Carvalho
O Bacellar
W D Johnson
P2860
P304
P356
10.1172/JCI113969
P407
P577
1989-03-01T00:00:00Z